QQQ   374.48 (-0.74%)
AAPL   149.35 (-0.09%)
MSFT   309.45 (-0.42%)
FB   323.26 (-5.45%)
GOOGL   2,746.05 (-3.23%)
TSLA   905.41 (+1.28%)
AMZN   3,361.00 (-2.15%)
NVDA   228.25 (+0.59%)
BABA   177.74 (+0.18%)
NIO   39.07 (-2.25%)
CGC   13.37 (-4.77%)
GE   103.95 (+0.78%)
AMD   119.95 (+0.52%)
MU   67.54 (-1.60%)
T   25.56 (-0.78%)
F   16.39 (-0.97%)
ACB   7.09 (-3.80%)
DIS   168.99 (-1.37%)
PFE   42.89 (+0.07%)
BA   212.93 (-0.66%)
AMC   36.32 (-7.44%)
QQQ   374.48 (-0.74%)
AAPL   149.35 (-0.09%)
MSFT   309.45 (-0.42%)
FB   323.26 (-5.45%)
GOOGL   2,746.05 (-3.23%)
TSLA   905.41 (+1.28%)
AMZN   3,361.00 (-2.15%)
NVDA   228.25 (+0.59%)
BABA   177.74 (+0.18%)
NIO   39.07 (-2.25%)
CGC   13.37 (-4.77%)
GE   103.95 (+0.78%)
AMD   119.95 (+0.52%)
MU   67.54 (-1.60%)
T   25.56 (-0.78%)
F   16.39 (-0.97%)
ACB   7.09 (-3.80%)
DIS   168.99 (-1.37%)
PFE   42.89 (+0.07%)
BA   212.93 (-0.66%)
AMC   36.32 (-7.44%)
QQQ   374.48 (-0.74%)
AAPL   149.35 (-0.09%)
MSFT   309.45 (-0.42%)
FB   323.26 (-5.45%)
GOOGL   2,746.05 (-3.23%)
TSLA   905.41 (+1.28%)
AMZN   3,361.00 (-2.15%)
NVDA   228.25 (+0.59%)
BABA   177.74 (+0.18%)
NIO   39.07 (-2.25%)
CGC   13.37 (-4.77%)
GE   103.95 (+0.78%)
AMD   119.95 (+0.52%)
MU   67.54 (-1.60%)
T   25.56 (-0.78%)
F   16.39 (-0.97%)
ACB   7.09 (-3.80%)
DIS   168.99 (-1.37%)
PFE   42.89 (+0.07%)
BA   212.93 (-0.66%)
AMC   36.32 (-7.44%)
QQQ   374.48 (-0.74%)
AAPL   149.35 (-0.09%)
MSFT   309.45 (-0.42%)
FB   323.26 (-5.45%)
GOOGL   2,746.05 (-3.23%)
TSLA   905.41 (+1.28%)
AMZN   3,361.00 (-2.15%)
NVDA   228.25 (+0.59%)
BABA   177.74 (+0.18%)
NIO   39.07 (-2.25%)
CGC   13.37 (-4.77%)
GE   103.95 (+0.78%)
AMD   119.95 (+0.52%)
MU   67.54 (-1.60%)
T   25.56 (-0.78%)
F   16.39 (-0.97%)
ACB   7.09 (-3.80%)
DIS   168.99 (-1.37%)
PFE   42.89 (+0.07%)
BA   212.93 (-0.66%)
AMC   36.32 (-7.44%)
CNSX:KBB

Kaneh Bosm Biotechnology Stock Forecast, Price & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume3.33 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive KBB News and Ratings via Email

Sign-up to receive the latest news and ratings for Kaneh Bosm Biotechnology and its competitors with MarketBeat's FREE daily newsletter.


About Kaneh Bosm Biotechnology

Kaneh Bosm Biotechnology Inc., formerly Anexco Resources Ltd., operates in the cannabis sector. The Company focuses on the deployment of kiosks to ultimate retail locations, and is evaluating various gold and lithium mining assets for potential acquisition. The Company is focused on identifying, acquiring and developing projects with a focus on precious metals deposits. The Company entered into a purchase agreement with Alps Innovations Group Inc. for North and South American rights to an intelligent automated retail kiosk, the BioCanna ADM Automated Cannabis retail system, for the dispensing of cannabis and related products in both medical and commercial markets (the Agreement). BioCanna ADM system is an automated dispensing machine, which is a hybrid between a bank automatic teller machine (ATM), and an intelligent retail kiosk. It operates its engineering, procurement and construction (EPC) division, a full-service engineering, procurement and construction service.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
N/A
Sector
N/A
CIK
N/A
Web
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Kaneh Bosm Biotechnology (CNSX:KBB) Frequently Asked Questions

What stocks does MarketBeat like better than Kaneh Bosm Biotechnology?

Wall Street analysts have given Kaneh Bosm Biotechnology a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Kaneh Bosm Biotechnology wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Kaneh Bosm Biotechnology's key executives?

Kaneh Bosm Biotechnology's management team includes the following people:
  • Michael Martinz, President, Director
  • Rudy de Jonge, Chief Executive Officer, Director
  • Anthony Jackson, Chief Financial Officer (Age 34)
  • Kent Ausburn Ph.D., Chief Operating Officer, Director
  • Matthew Wyatt Lechtzier, Director (Age 53)

What other stocks do shareholders of Kaneh Bosm Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kaneh Bosm Biotechnology investors own include Jubilee Metals Group (JLP), 156478 (DDD.L) (DDD), Clontarf Energy (CLON) and ADVFN (AFN).

What is Kaneh Bosm Biotechnology's stock symbol?

Kaneh Bosm Biotechnology trades on the CNSX under the ticker symbol "KBB."

How do I buy shares of Kaneh Bosm Biotechnology?

Shares of KBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Where are Kaneh Bosm Biotechnology's headquarters?

Kaneh Bosm Biotechnology is headquartered at 675 Hastings St W Suite 810, VANCOUVER, BC V6B 1N2, Canada.

How can I contact Kaneh Bosm Biotechnology?

Kaneh Bosm Biotechnology's mailing address is 675 Hastings St W Suite 810, VANCOUVER, BC V6B 1N2, Canada. The company can be reached via phone at +1-604-2831722.


This page was last updated on 10/22/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.